These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6957154)
1. Nutritional & pharmacologic management of hyperlipoproteinemia. Pickering JE Angiology; 1982 Sep; 33(9):577-80. PubMed ID: 6957154 [TBL] [Abstract][Full Text] [Related]
2. Clinical results with gemfibrozil. Pickering JE Am J Cardiol; 1983 Aug; 52(4):39B-40B. PubMed ID: 6351579 [No Abstract] [Full Text] [Related]
3. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate. Nye ER; Sutherland WH; Temple Wa N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550 [TBL] [Abstract][Full Text] [Related]
4. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. Kesäniemi YA; Grundy SM JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883 [TBL] [Abstract][Full Text] [Related]
5. Treatment of type III hyperlipoproteinemia with four different treatment regimens. Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975 [TBL] [Abstract][Full Text] [Related]
6. Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study. Manninen V; Mälkönen M; Eisalo A; Virtamo J; Tuomilehto J; Kuusisto P Acta Med Scand Suppl; 1982; 668():82-7. PubMed ID: 6762809 [No Abstract] [Full Text] [Related]
8. Influence of gemfibrozil on high-density lipoproteins. Glueck C Am J Cardiol; 1983 Aug; 52(4):31B-34B. PubMed ID: 6577782 [TBL] [Abstract][Full Text] [Related]
9. Gemfibrozil treatment and the relationship between HDL cholesterol and apoE distribution in cholesterol-fed rats. Krause BR; Newton RS Atherosclerosis; 1986 Sep; 61(3):245-8. PubMed ID: 3464282 [No Abstract] [Full Text] [Related]
10. A pilot study of the effect of Gemfibrozil on some haematological parameters. O'Brien JR; Etherington MD; Shuttleworth RD; Adams CM; Middleton JE; Goodland FC Thromb Res; 1982 May; 26(4):275-9. PubMed ID: 6955993 [TBL] [Abstract][Full Text] [Related]
12. Clinical results with gemfibrozil and background to the Helsinki Heart Study. Manninen V Am J Cardiol; 1983 Aug; 52(4):35B-38B. PubMed ID: 6351578 [No Abstract] [Full Text] [Related]
15. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia. Lewis JE Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156 [TBL] [Abstract][Full Text] [Related]
16. Gemfibrozil plus cholestyramine in familial hypercholesterolaemia. Jones AF; Hughes EA; Cramb R Lancet; 1988 Apr; 1(8588):776. PubMed ID: 2895309 [No Abstract] [Full Text] [Related]
17. Combination drug therapy for familial combined hyperlipidemia. East C; Bilheimer DW; Grundy SM Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemia. Larsen ML; Illingworth DR; O'Malley JP Atherosclerosis; 1994 Apr; 106(2):235-40. PubMed ID: 8060383 [TBL] [Abstract][Full Text] [Related]
19. The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus. Chang DM; Fuh MM; Jeng CY; Shian LR Taiwan Yi Xue Hui Za Zhi; 1986 May; 85(5):443-50. PubMed ID: 3463653 [No Abstract] [Full Text] [Related]
20. Studies on hypoxic dyslipidaemia. Effect of lipid modulating drugs. Mälkönen M; Muona M; Manninen V Acta Med Scand Suppl; 1982; 668():130-5. PubMed ID: 6963088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]